Effects of ursodeoxycholic acid on proinflammatory cytokines in children with infantile hepatitis syndrome
Zhu Le
Abstract
Zhu Le
Abstract
AIM: To observe the effect of ursodeoxycholic acid( UDCA) on the treatment of infantile hepatitis syndrome( HIS) and to investigate its mechanism. METHODS: The children with infantile hepatitis syndrome were divided into conventional treatment group and the UDCA treatment group. Twenty healthy children were selected as normal control. The children in conventional therapy group were given antiviral and hepatoprotective treatments. The children in UDCA treatment group were given ursodeoxycholic acid( 10 mg·kg- 1·d- 1) in addition to the conventional treatment group for 2 to 3 weeks. The levels of total bilirubin( TBIL),direct bilirubin( DBIL),alanine aminotransferase( ALT),glutamyltransferase( GGT),total bile acids( TBA) and TNF-α,IL-6 were detected before admission and 2 weeks later. RESULTS: The levels of TNF-α and IL-6 were significantly higher in the children with IHS than those in the normal control( P 0. 01). The levels of TBIL,DBIL,ALT,GGT,TBA,TNF-α and IL-6 in conventional treatment group were reduced after therapy( P 0. 01). All the above index in UDCA treatment group were decreased compared with conventional treatment group( P 0. 01). CONCLUSION: On the basis of conventional therapy,ursodeoxycholic acid effectively alleviates the systemic inflammatory response in the children with IHS,reduces the liver damages.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To observe the effect of ursodeoxycholic acid( UDCA) on the treatment of infantile hepatitis syndrome( HIS) and to investigate its mechanism. METHODS: The children with infantile hepatitis syndrome were divided into conventional treatment group and the UDCA treatment group. Twenty healthy children were selected as normal control. The children in conventional therapy group were given antiviral and hepatoprotective treatments. The children in UDCA treatment group were given ursodeoxycholic acid( 10 mg·kg- 1·d- 1) in addition to the conventional treatment group for 2 to 3 weeks. The levels of total bilirubin( TBIL),direct bilirubin( DBIL),alanine aminotransferase( ALT),glutamyltransferase( GGT),total bile acids( TBA) and TNF-α,IL-6 were detected before admission and 2 weeks later. RESULTS: The levels of TNF-α and IL-6 were significantly higher in the children with IHS than those in the normal control( P 0. 01). The levels of TBIL,DBIL,ALT,GGT,TBA,TNF-α and IL-6 in conventional treatment group were reduced after therapy( P 0. 01). All the above index in UDCA treatment group were decreased compared with conventional treatment group( P 0. 01). CONCLUSION: On the basis of conventional therapy,ursodeoxycholic acid effectively alleviates the systemic inflammatory response in the children with IHS,reduces the liver damages.
Key concepts: Ursodeoxycholic acid, Medicine, Gastroenterology, Internal medicine, Bilirubin, Proinflammatory cytokine, Bile acid, Alanine aminotransferase